Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer.

Mohajer, Jonathan; Dunlop, Alex; Mitchell, Adam; Goodwin, Edmund; Nill, Simeon; Oelfke, Uwe; Tree, Alison.

Afiliação

Mohajer J; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Dunlop A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Mitchell A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Goodwin E; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Nill S; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Oelfke U; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.
Tree A; Department of Urology, The Royal Marsden NHS Foundation Trust, 15 Cotswold Road, London, Surrey SM2 5NG, UK.

Clin Transl Radiat Oncol ; 26: 1-7, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33241129